TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07654751: A Phase 4, Open-Label, Milk-Only Lactation Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically

Sponsor: Janssen Research & Development, LLC · Phase: PHASE4 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 20 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$309,600

Rescue Site Savings

+$206,400

Unlock Full NCT07654751 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07654751 Rescue Dossier →